21:04:42 EST Wed 04 Mar 2026
Enter Symbol
or Name
USA
CA



High Tide Inc (2)
Symbol HITI
Shares Issued 87,891,385
Close 2026-03-04 C$ 3.38
Market Cap C$ 297,072,881
Recent Sedar+ Documents

High Tide, NuLeaf join U.S. Compassionate Care Council

2026-03-04 17:16 ET - News Release

Mr. Raj Grover reports

HIGH TIDE AND NULEAF NATURALS JOIN U.S. NATIONAL COMPASSIONATE CARE COUNCIL AS FOUNDING MEMBERS

High Tide Inc.'s United States hemp-derived CBD subsidiary, NuLeaf Naturals, has joined the National compassionate Care Council (NCCC) as founding members.

"Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, founder and chief executive officer of High Tide. "Through our experience building health-focused brands such as NuLeaf Naturals and FAB CBD, we have developed meaningful expertise in serving consumers seeking cannabinoid-based wellness products within a responsible regulatory framework. We are pleased to join the NCCC so that High Tide and NuLeaf can help contribute to the development of thoughtful U.S. federal and state medical cannabis policy, while supporting efforts aimed at improving patient access to cannabinoid therapies across the United States," added Mr. Grover.

The NCCC is dedicated to improving patient access to cannabinoid therapies by modernizing health care standards and advancing evidence-based policy. The council brings together health-care-focused organizations across the medicinal cannabis sector that prioritize product quality, research and patient outcomes.

In addition to High Tide and its subsidiaries NuLeaf Naturals and FAB CBD, founding members include Feals, Medterra CBD LLC, Tilray Inc., Realm of Caring, Lazarus Naturals, Constance CBD and Equilibria.

Recent federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoid products signal a potential shift in U.S. health care policy that can have a material impact for High Tide's U.S.-based hemp-derived CBD subsidiaries. Through its participation in the NCCC, High Tide aims to contribute industry expertise while supporting broader efforts to expand patient access to safe and effective cannabinoid therapies.

About High Tide Inc.

High Tide is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely built around the cannabis consumer, with wholly diversified and fully integrated operations across all components of cannabis, including:

Retail: Canna Cabana is the largest cannabis retail chain in Canada, with 219 domestic locations. The company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, holding a growing 12-per-cent share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.

Medical cannabis distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's top growing companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked No. 1 in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.